Hematology and Oncology
EPA Sets Strict Limit on PFAS ‘Forever Chemicals’ in U.S. Drinking Water
FDA Approves Abecma for Relapsed, Refractory Multiple Myeloma
Phase 3 trial shows 51 percent reduction in the risk for disease progression or death in triple-class exposed patients
EPA Issues New Rules to Reduce Airborne Toxins From Chemical Plants
Companies will be required to conduct 'fenceline monitoring' aimed at spotting dangerous chemical leaks
AACR: Accelerated Aging Linked to Incidence of Early-Onset Cancer
Accelerated aging associated with increased risk for early-onset tumors, driven by lung, gastrointestinal, uterine cancers
Caring for Child With Cancer Increases Mental Health Care Utilization for Parents
Increases seen in total mental health-related visits as well as anxiety- or depression-related visits
AACR: Novel Personalized Vaccine Feasible for Head and Neck Cancer
Vaccination found to be safe and induces polyclonal immune responses against vaccine targets
AACR: Cadonilimab Plus Chemo Beneficial for Gastric Adenocarcinoma
Improved overall survival, progression-free survival seen, including among patients with low PD-L1 expression
Single Invitation for PSA Screening Cuts Prostate Cancer Deaths
Small, but significant reduction seen in prostate cancer deaths, but no reduction seen in all-cause mortality
Immersive Virtual Reality Beneficial for Pain Relief in Cancer
VR provides more nonpharmacologic pain relief than an active control, and the benefit was sustained
AACR: Exosome-Based miRNA Assay Can Detect Pancreatic Cancer
Signature resulting from combining cell-free-miRNAs, exosomal-miRNAs distinguished patients with PDAC from healthy donors
